HQY: Leadership change

Item 5.02(b) Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. The employment of Michael Fiore, the Chief Commercial Officer at HealthEquity, Inc. (the “Company”), was terminated by the Company without cause, effective October 5, 2026. The responsibilities of the Chief Commercial Officer will be redistributed to other members of the Company’s management team. In consideration of Mr. Fiore’s execution, delivery, and non-revocation of the release of claims against the Company and its subsidiaries and affiliates substantially in the form attached to his employment agreement, and his continuing compliance with certain restrictive covenants contained therein, Mr. Fiore will receive the previously negotiated severance payments and benefits set forth in his employment agreement, as detailed in the Company’s most recent proxy statement filed with the Securities and Exchange Commission on May 13, 2026, and his outstanding equity awards will be treated in a manner consistent with the terms of the 2014 Stock Incentive Plan, the 2024 Stock Incentive Plan, and his applicable award agreements, each as previously filed. - 2 - SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HEALTHEQUITY, INC. Date: October 9, 2026 By: /s/ James Lucania Name: James Lucania Title: Executive Vice President and Chief Financial Officer - 3 -